ɪtɹˈɛtᵻnˌeɪt tɹˈeɪd nˈeɪm tˈɛdʒɪsən ɪz ɐ mˌɛdɪkˈeɪʃən dɪvˈɛləpt baɪ hˈɑːfmən lˌæ ɹˈɑːtʃ ðæt wʌz ɐpɹˈuːvd baɪ ðɪ ˌɛfdˌiːˈeɪ ɪn nˈaɪntiːnhˈʌndɹɪd ˈeɪɾi sˈɪks tə tɹˈiːt sᵻvˈɪɹ sˌoːɹɪˈɑːsiz.
Etretinate (trade name Tegison) is a medication developed by Hoffmann–La Roche that was approved by the FDA in 1986 to treat severe psoriasis.